10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Antimicrobial therapy plays a pivotal role in combating infectious diseases, employing agents that target and eliminate microorganisms. Antibiotics, a subset of antimicrobials, are widely used to treat bacterial infections. They work by inhibiting bacterial growth or destroying the bacteria, offering effective solutions for a range of illnesses. However, overuse and misuse of antibiotics contribute to the emergence of drug-resistant strains, underscoring the need for judicious antibiotic stewardship. Antiviral drugs are designed to combat viral infections by inhibiting viral replication or entry into host cells. Antifungal agents target fungal pathogens, addressing conditions like candidiasis or aspergillosis. The continuous development of new antimicrobial therapies remains essential to stay ahead of evolving resistance patterns, ensuring effective treatment options for infectious diseases.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria